Abnormal DNA Methylation in Thoracic Spinal Cord Tissue Following Transection Injury

Area of Science:

• Epigenetics
• Neuroscience
• Molecular Biology

Background:

• Spinal cord injury (SCI) is a debilitating condition with limited therapeutic options.
• Abnormal DNA methylation is implicated in SCI, potentially affecting axonal regeneration and cell proliferation.
• The specific roles of key genes in SCI molecular mechanisms remain unclear.

Purpose of the Study:

• To investigate the epigenetic changes, specifically DNA methylation, in spinal cord injury.
• To identify key genes and signaling pathways involved in the molecular mechanisms of SCI.
• To correlate DNA methylation patterns with functional and histological outcomes post-SCI.

Main Methods:

• Establishment of subacute spinal cord injury models in Wistar rats.
• Histological examination and motor function assessment.
• Whole-genome bisulfite sequencing (WGBS) for DNA methylation analysis.
• Bioinformatic analyses including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis.
• Protein-protein interaction (PPI) network analysis.
• Quantitative real-time polymerase chain reaction (qRT-PCR) for gene expression validation.

Main Results:

• Histological analysis revealed tissue damage and inflammation, with low motor function scores post-SCI.
• WGBS identified approximately 96 differentially methylated genes (DMGs), with 50 hypermethylated and 46 hypomethylated.
• KEGG pathway analysis highlighted the Axon Guidance, Endocytosis, T cell receptor signaling, and Hippo signaling pathways.
• Gene expression patterns from qRT-PCR were significantly opposite to WGBS methylation data.

Conclusions:

• Abnormal DNA methylation and key signaling pathways are significantly involved in spinal cord injury.
• The identified methylated genes and pathways provide a deeper understanding of SCI's epigenetic landscape.
• This research offers potential targets for future therapeutic strategies aimed at mitigating SCI consequences.